[HTML][HTML] Long COVID and its Management

HC Koc, J Xiao, W Liu, Y Li, G Chen - International Journal of …, 2022 - ncbi.nlm.nih.gov
The pandemic of COVID-19 is the biggest public health crisis in 21 st Century. Besides the
acute symptoms after infection, patients and society are also being challenged by the long …

[HTML][HTML] Clinical outcomes associated with SARS-CoV-2 Omicron (B. 1.1. 529) variant and BA. 1/BA. 1.1 or BA. 2 subvariant infection in Southern California

JA Lewnard, VX Hong, MM Patel, R Kahn, M Lipsitch… - Nature medicine, 2022 - nature.com
Epidemiologic surveillance has revealed decoupling of Coronavirus Disease 2019 (COVID-
19) hospitalizations and deaths from case counts after emergence of the Omicron (B. 1.1 …

Clinical outcomes among patients infected with Omicron (B. 1.1. 529) SARS-CoV-2 variant in southern California

JA Lewnard, VX Hong, MM Patel, R Kahn, M Lipsitch… - MedRxiv, 2022 - medrxiv.org
ABSTRACT Background The Omicron (B. 1.1. 529) variant of SARS-CoV-2 has rapidly
achieved global dissemination, accounting for most infections in the United States by …

[HTML][HTML] Evolution and control of COVID-19 epidemic in Hong Kong

SC Wong, AKW Au, JYC Lo, PL Ho, IFN Hung, KKW To… - Viruses, 2022 - mdpi.com
Hong Kong SAR has adopted universal masking, social distancing, testing of all
symptomatic and high-risk groups for isolation of confirmed cases in healthcare facilities …

[HTML][HTML] Association of Molnupiravir and Nirmatrelvir-Ritonavir with preventable mortality, hospital admissions and related avoidable healthcare system cost among …

AKC Wai, CY Chan, AWL Cheung, K Wang… - The Lancet Regional …, 2023 - thelancet.com
Background Real-world data is currently limited on the association between oral antiviral
therapy and healthcare system burden in patients with mild-to-moderate COVID-19. This …

[HTML][HTML] An intranasal influenza virus-vectored vaccine prevents SARS-CoV-2 replication in respiratory tissues of mice and hamsters

S Deng, Y Liu, RCY Tam, P Chen, AJ Zhang… - Nature …, 2023 - nature.com
Current available vaccines for COVID-19 are effective in reducing severe diseases and
deaths caused by SARS-CoV-2 infection but less optimal in preventing infection. Next …

Estimation of disease burden and clinical severity of COVID-19 caused by Omicron BA. 2 in Shanghai, February-June 2022

X Chen, X Yan, K Sun, N Zheng, R Sun… - Emerging microbes & …, 2022 - Taylor & Francis
An outbreak of COVID-19 caused by the SARS-CoV-2 Omicron BA. 2 sublineage occurred
in Shanghai, China from February 26 to June 30, 2022. We use official reported data …

Geriatric risk and protective factors for serious COVID-19 outcomes among older adults in Shanghai Omicron wave

G Lu, Y Zhang, H Zhang, J Ai, L He… - Emerging microbes & …, 2022 - Taylor & Francis
Shanghai has been experiencing the Omicron wave since March 2022. Though several
studies have evaluated the risk factors of severe infections, the analyses of BA. 2 infection …

[HTML][HTML] The association between risk perception and hesitancy toward the booster dose of COVID-19 vaccine among people aged 60 years and older in China

C Qin, W Yan, L Tao, M Liu, J Liu - Vaccines, 2022 - mdpi.com
Background: Given the prevalence of the omicron variant and decreased immunity provided
by vaccines, it is imperative to enhance resistance to COVID-19 in the old population. We …

[HTML][HTML] Resurgence of omicron BA. 2 in SARS-CoV-2 infection-naive Hong Kong

R Xie, KM Edwards, DC Adam, KSM Leung… - Nature …, 2023 - nature.com
Hong Kong experienced a surge of Omicron BA. 2 infections in early 2022, resulting in one
of the highest per-capita death rates of COVID-19. The outbreak occurred in a dense …